Randomized Continuation, Dose Escalation Trial of Sorafenib in Patients With Advanced HCC With Radiological Progression on Prior Sorafenib Treatment (Phase II Study).
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 01 Sep 2010 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 22 Sep 2008 Actual patient number (333) added as reported by ClinicalTrials.gov.